Financial Regulation

United Wealth Education claims an FTC lawsuit made it stronger. The FTC is busy sending $10.9M to consumers harmed by what it called a 'pyramid scheme.'

Hologram firm HOLO unveils a simplified quantum authentication method, backed by a massive investment to challenge the future of cybersecurity.

After a year-long legal battle over alleged fentanyl precursor sales, the U.S. Department of Justice has dismissed all charges against Vasudha Pharma Chem.

A new startup is emerging from stealth with $6M from Kleiner Perkins to automate the mortgage process, aiming to slash costs and closing times.

A new AI platform from ThinkTrends is revolutionizing FDA adverse event reporting, promising $120M in savings and dramatically faster public health insights.

Following a $295M exploit, Solana DEX Drift Protocol gets a lifeline from Tether, plotting a relaunch that will reshape the ecosystem's stablecoin landscape.

A new survey shows nearly half of employers are considering international drug sourcing, a legally murky strategy, as cost control dethrones talent retention.

A Pennsylvania firm's acquisition of a New Jersey specialist reflects a larger trend of industry consolidation and a growing demand for enhanced fund security.

A new AI platform is revolutionizing how pharma creates complex scientific videos, earning industry award recognition for its speed, savings, and compliance.

A new partnership integrates expert rater training with eCOA tech, aiming to reduce costly data errors and accelerate development of new neurological drugs.

Hashgraph partners with elite security firm Halborn to proactively secure the Hedera network, aiming to win enterprise trust and fuel Web3 innovation.

Gaia Interactive, backed by Stripe's Bridge, unveils its GUSD stablecoin, aiming to disrupt cross-border payments with a focus on regulation and speed.

A proposed $108.5M FDA funding boost aims to modernize infant formula rules, paving the way for plant-based options and a more secure supply chain.

ASIC reports a smaller loss but slumping revenue as it sells key NYC properties. With low cash and NYSE warnings, is this a survival plan or a fire sale?

As digital asset fraud soars, one firm is using AI and a global network to chase stolen funds across borders, highlighting a new front in law enforcement.

From the nation's capital to pristine wilderness, a new report warns that unchecked development and pollution are pushing America's vital rivers to the brink.

Crypto hedge fund founder Zaheer Ebtikar joins Plasma as CSO, signaling a major push to launch Plasma One, a neobank built entirely on stablecoins.

With its lead depression drug nearing Phase 3, AtaiBeckley faces investors to tackle the regulatory and commercial hurdles of psychedelic medicine.

Accuity hires Cindy Klain, former exec at Optum and GE, to lead strategy as hospitals face mounting financial and regulatory pressures.

Nutraville's new brain supplement CogniSurge touts a 'glycocalyx' fix. We examine the science, the sales pitch, and what consumers should know.